What Quoin Pharmaceuticals Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 4 | 5 |
| Sells | 0 | 0 |
| Total trades | 6 | 7 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 7 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Myers Michael | Chief Executive Officer | Aug 31 | Open-market buy · P | +20,490 | $4.88 | +$100K | 37,713 |
| Carter Denise P. | Chief Operating Officer | Aug 31 | Open-market buy · P | +20,490 | $4.88 | +$100K | 37,709 |
| Lawlor Sally Bridget | Chief Financial Officer | Aug 31 | Open-market buy · P | +10,244 | $4.88 | +$50K | 10,684 |
| Culverwell Anthony James | Director | Aug 31 | Open-market buy · P | +6,146 | $4.88 | +$30K | 40,364 |
| Langer Dennis | Director | Aug 27 | Grant / award · A | +34,534 | $5.15 | +$178K | 56,243 |
| Culverwell Anthony James | Director | Aug 27 | Grant / award · A | +31,352 | $5.15 | +$161K | 34,218 |
| Langer Dennis | Director | Oct 14 | Open-market buy · P | +15,152 | $8.49 | +$129K | 15,153 |
| Dunn Gordon | Chief Financial Officer | Dec 23 | Open-market buy · P | +122,221 | $0.45 | +$55K | 151,077 |
| Culverwell Anthony James | Director | Dec 23 | Open-market buy · P | +100,000 | $0.45 | +$45K | 100,317 |
| Myers Michael | Chief Executive Officer | Dec 23 | Open-market buy · P | +555,556 | $0.45 | +$250K | 602,808 |
| Carter Denise P. | Chief Operating Officer | Dec 23 | Open-market buy · P | +555,556 | $0.45 | +$250K | 602,648 |
| Dunn Gordon | Chief Financial Officer | Sep 10 | Open-market buy · P | +10,000 | $0.71 | +$7.1K | 28,856 |
| Dunn Gordon | Chief Financial Officer | Sep 10 | Open-market buy · P | +10,000 | $0.91 | +$9.1K | 18,856 |
| Dunn Gordon | Chief Financial Officer | Sep 09 | Open-market buy · P | +4,000 | $0.80 | +$3.2K | 8,856 |
| Dunn Gordon | Chief Financial Officer | Sep 09 | Open-market buy · P | +4,000 | $0.78 | +$3.12K | 4,856 |
| Dunn Gordon | Chief Financial Officer | Sep 09 | Open-market buy · P | +856 | $0.80 | +$685 | 856 |
| Carter Denise P. | Chief Operating Officer | Sep 04 | Open-market buy · P | +22,988 | $0.80 | +$18.3K | 47,092 |
| Carter Denise P. | Chief Operating Officer | Sep 04 | Open-market buy · P | +8,825 | $0.75 | +$6.6K | 24,104 |
| Myers Michael | Chief Executive Officer | Sep 04 | Open-market buy · P | +23,572 | $0.80 | +$18.8K | 47,252 |
| Myers Michael | Chief Executive Officer | Sep 04 | Open-market buy · P | +8,200 | $0.75 | +$6.13K | 23,680 |
Loading...